Actively Recruiting

Age: 65Years - 100Years
All Genders
NCT05741593

Qualitative Analysis of Interviews Between Pharmacist and Elderly Patients Treated with Antithrombotics for an Ischemic Stroke.

Led by Hospices Civils de Lyon · Updated on 2024-11-18

30

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. There are brakes and levers of medication adherence in the context of secondary prevention treatment in stroke.

CONDITIONS

Official Title

Qualitative Analysis of Interviews Between Pharmacist and Elderly Patients Treated with Antithrombotics for an Ischemic Stroke.

Who Can Participate

Age: 65Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 65 and over
  • Hospitalized for ischemic stroke or recurrence and already treated with antithrombotic medication
  • Living at home or planning to return home
  • Provided consent for recording of the interview
Not Eligible

You will not qualify if you...

  • Cognitive disorders or stroke effects preventing participation in interview (per medical judgment)
  • Non-French speaking patients

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

institute of aging - Hôpital des Charpennes

Villeurbanne, France, 69100

Actively Recruiting

Loading map...

Research Team

T

Teddy Novais, PharmD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Qualitative Analysis of Interviews Between Pharmacist and Elderly Patients Treated with Antithrombotics for an Ischemic Stroke. | DecenTrialz